Orthopedic Industry Executives Examine Top Growth Opportunities

About Video

Today’s orthopedic growth opportunities largely align with two strategies — responding to the shifts in care settings and adopting enabling and digital technology. An orthopedic company’s ability to design innovative implants and master market introductions is no longer enough to keep pace with the evolving healthcare landscape. Companies will achieve accelerated growth if they understand, predict and answer the needs of their surgeon and hospital customers by marrying traditional products with ASC or digital strategies.

The OMTEC keynote brought together diverse perspectives representing orthopedic and spine company leadership, surgeon and practice/hospital management. Their dialogue offers insight into the significant changes shaping hospital and ASC decision-making, the enabling technology and digital tools that will prevail in orthopedics, and the new business models companies will assume and navigate in the next five years. This powerful panel discussion is paired with a presentation of ORTHOWORLD’s proprietary market projections and observations to provide a high-level industry forecast.

About speaker/s

Michael Evers is a Senior Market Analyst and writer at ORTHOWORLD. He leads the development of ORTHOWORLD’s proprietary revenue models, covers industry trends and co-authors THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT. Before joining ORTHOWORLD in 2018, Mr. Evers served in analyst roles within the cardiac rhythm management and physician practice management industries.

Rob Ball is a Director at Genesis Innovation Group and CEO of two of its portfolio companies, Shoulder Innovations and Magnesium Development Company. Mr. Ball has spent more than two decades bringing medical device technologies to market, including proprietary orthopedic materials. He served at Tornier as Global Vice President, Research and Development, during which time the company grew from approximately $70 million to $300 million in annual revenues through organic growth of new products. Prior roles include Vice President of Marketing and Product Development at Kinetikos Medical and R&D Engineer at DePuy Orthopaedics. Mr. Ball holds more than 30 issued or pending patents.

Wael Barsoum, M.D., is an innovative, value-driven orthopedic surgeon with 20+ years of experience in promoting growth, performance and leading change. As President and Chief Transformation Officer, Dr. Barsoum leads HOPCo’s market transformation initiatives by further aligning stakeholders to continue the shift from volume-based care to value-based care models. He also oversees HOPCo’s musculoskeletal service line hospital integration, musculoskeletal specialty hospitals, quality programs and operational teams. Prior to joining HOPCo, Dr. Barsoum served as the CEO and President of Cleveland Clinic Florida. During his tenure, Dr. Barsoum cultivated and transformed Cleveland Clinic Florida from a $600 million, single, 155-bed hospital system with nine remote sites to a $1.8 billion, five-hospital, 1,083-bed tertiary and quaternary care hospital system with over 40 regional sites.

Kevin McGann is the President and CEO of Accelus. He previously served as Chief Commercial Officer of Accelus and its predecessor company Integrity Implants. Prior to this, Mr. McGann served as the President and Chief Executive Officer of Kallista Partners from 2017 to 2019. Additionally, Mr. McGann served as the Vice President of Sales of Stryker from 2015 to 2017. Mr. McGann holds a B.S. in Business Administration from Villanova University.

Nitin Goyal, M.D. is Chief Science, Technology, and Innovation Officer for Zimmer Biomet. He leads all of R&D, M&A strategy, clinical research, and medical education across the global businesses. Prior to joining Zimmer Biomet, Dr. Goyal served as Chief Medical Officer and Senior Vice President of Innovation and Digital Care Delivery at Optum, the health services business of UnitedHealth Group. In addition, he was the Founder and CEO of Pulse Platform as well as Surgical Creations, leading both companies from inception to acquisition. Dr. Goyal continues in clinical practice at the Anderson Orthopaedic Clinic in Alexandria, Virginia where he has been since 2011.

No matter your station in the orthopedic commercialization chain — engineer, executive, buyer, surgeon, investor, inventor, manufacturer — OMTEC is your resource.